Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.
about
A Comparison Between NOACs and Warfarin on Time to Elective CardioversionBleeding events associated with a low dose (110 mg) versus a high dose (150 mg) of dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysisManagement of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.A Comparison Between Dabigatran and Warfarin on Time to Elective Cardioversion.The Nonvitamin K Antagonist Oral Anticoagulants and Atrial Fibrillation: Challenges and Considerations.Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence.Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion.Cardioversion of atrial fibrillation in a real-world setting: non-vitamin K antagonist oral anticoagulants ensure a fast and safe strategy compared to warfarin.Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a prospective propensity score-matched cohort study.Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation.
P2860
Q28073153-E0E4DDC1-4768-4E24-823E-C5DB396DFF2AQ36309584-02101532-1BFC-407C-9519-17BE0336F1D9Q38975409-B063C00B-2900-4322-91E8-9372336FEB08Q41640269-4B6F2EAA-6E48-4D65-9A5A-A353213FE4F5Q47118947-30949FE1-94F8-49C1-B56B-CB8870E7CBC9Q47741252-836B7B5B-8ADB-46FB-B432-51356490FCDBQ47827695-2E32B4B5-6C90-4FE5-9030-57E778BD0D5BQ48739342-B56BAF5B-93FF-4C7E-A7CF-2F35E559BD07Q50867082-6E5267FE-2696-417C-95F5-C6FEB53CF3B5Q55055702-B58BD7FB-3319-481B-B949-A5C6F7AFB4A3
P2860
Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cardioversion and Risk of Adve ...... rin-A Nationwide Cohort Study.
@ast
Cardioversion and Risk of Adve ...... rin-A Nationwide Cohort Study.
@en
type
label
Cardioversion and Risk of Adve ...... rin-A Nationwide Cohort Study.
@ast
Cardioversion and Risk of Adve ...... rin-A Nationwide Cohort Study.
@en
prefLabel
Cardioversion and Risk of Adve ...... rin-A Nationwide Cohort Study.
@ast
Cardioversion and Risk of Adve ...... rin-A Nationwide Cohort Study.
@en
P2093
P2860
P50
P1433
P1476
Cardioversion and Risk of Adve ...... rin-A Nationwide Cohort Study.
@en
P2093
Anne-Marie Schjerning
Jannik Langtved Pallisgaard
Laila Staerk
Morten Lock Hansen
Tommi Bo Lindhardt
P2860
P304
P356
10.1371/JOURNAL.PONE.0141377
P407
P577
2015-10-29T00:00:00Z